Search

Your search keyword '"Travis, Simon P."' showing total 633 results

Search Constraints

Start Over You searched for: Author "Travis, Simon P." Remove constraint Author: "Travis, Simon P."
633 results on '"Travis, Simon P."'

Search Results

1. A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease

4. Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards

9. Divergent trajectories of antiviral memory after SARS-CoV-2 infection

10. Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease

11. IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies

12. Clinical Performance Status and Technical Factors Affecting Outcomes from Percutaneous Transhepatic Biliary Interventions; A Multicentre, Prospective, Observational Cohort Study

13. The continuing value of mesalazine as first-line therapy for patients with moderately active ulcerative colitis.

21. Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial

22. Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease

23. Development of the Crohn's disease digestive damage score, the Lémann score.

25. 1139 UNITED STATES AND EUROPEAN PATIENT PERSPECTIVES ON THE IMPACT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS ON SEXUAL ACTIVITY: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

28. Biallelic TLR4 deficiency in humans

29. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial

32. Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study

33. Development of the Escalation of Therapy or Intervention (ETI) Calculator for Patients with Ulcerative Colitis Using ePROMs.

35. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial

38. Application of Deep Learning Models to Improve Ulcerative Colitis Endoscopic Disease Activity Scoring Under Multiple Scoring Systems

39. CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease

40. Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response

45. Artificial Intelligence in Inflammatory Bowel Disease Endoscopy: Implications for Clinical Trials.

48. Patient-reported Outcomes: the ICHOM Standard Set for Inflammatory Bowel Disease in Real-life Practice Helps Quantify Deficits in Current Care

49. Targeted versus universal tuberculosis chemoprophylaxis in 1968 patients with inflammatory bowel disease receiving anti‐TNF therapy in a tuberculosis endemic region

50. Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease.

Catalog

Books, media, physical & digital resources